To assess whether bezafibrate increases fatty acid oxidation ( FAO ) and lowers heart rate ( HR ) during exercise in patients with carnitine palmitoyltransferase ( CPT ) II and very long-chain acyl-CoA dehydrogenase ( VLCAD ) deficiencies .